Product Details:
Minimum Order Quantity | 1 Unit |
Manufacturer | ASTRAZENECA |
Treatment | TUMOURS |
Prescription/Non prescription | Prescription |
Usage/Application | Hospital |
Brand | CAPRELSA |
Dose Strength | 300MG |
Dose/Strength | 300 mg |
Usage | Clinic, Hospital, Personal |
Packaging Type | Box |
Additional Information:
Product Details:
Minimum Order Quantity | 1 Unit |
Dose | 800mg |
Packaging Type | Vial |
Packaging Size | Vial |
Usage | Hospital |
Portrazza (necitumumab) is a recombinant human lgG1 monoclonal antibody developed by Eli Lilly, for the treatment of metastatic squamous non-small cell lung cancer (NSCLC).
Eli Lilly received approval from the US Food and Drug Administration (FDA) for Protrazza in combination with gemcitabine and cisplatin for the treatment of metastatic squamous NSCLC in November 2015. The drug was granted orphan designation by the FDA.
Product Details:
Minimum Order Quantity | 1 Unit |
Dosage Form (If Applicable) | Creams/Ointments |
Usage | Clinical, Personal, Hospital |
Product Type | Finished Product |
Form | Tube |
Product Details:
Dose/Strength | 150 mg |
Packaging Type | Plastic Bottle, Box |
Brand | Zydelig |
Form | Tablets |
Zydelig is indicated in combination with an anti-CD20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (CLL):
Zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (FL) that is refractory to two prior lines of treatment
Product Details:
Minimum Order Quantity | 1 Unit |
Form | Capsules |
Packaging Size | 120 Capsules |
Dose/Strength | 100 mg |
Packaging Type | Box |
Zolinza (vorinostat) is used to treat skin problems caused by cutaneous T-cell lymphoma. Zolinza is usually given after other treatments have been tried without successful treatment. Zolinza may also be used for purposes not listed in this medication guide.
Product Details:
Minimum Order Quantity | 1 Unit |
Dose/Strength | 1 g/0.5 g per vial |
Brand | Zerbaxa |
Usage | Clinic, Hospital |
Rubraca® (rucaparib) tablets are a prescription medicine used for:
Additional Information:
Product Details:
Usage | Personal, Clinical, Hospital |
Dose | 1200 mg/20 ml, 60 mg/ml |
Packaging Type | Glass Bottle |
Form of Medicine | Injection |
TECENTRIQ (atezolizumab) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who:
Product Details:
Minimum Order Quantity | 1 Unit |
Packaging Type | Plastic Bottle, Box |
Dose | 250 mg |
Form | Tablets |
Usage | Clinical, Hospital, Personal |
Product Details:
Minimum Order Quantity | 1 Unit |
Form | Tablets |
Packaging Size | 30 Tablets |
Dose/Strength | 40 mg/80 mg |
Packaging Type | Plastic Bottle |
Product Details:
Usage | Hospital, Personal, Clinical |
Dose | 200 mg |
Packaging Type | Box |
Form | Tablets |
Product Details:
Minimum Order Quantity | 1 Unit |
Dose | 100 mg / 1 ml/ (10 mg/ ml) |
Usage | Clinical, Hospital |
Packaging Type | Glass Bottle, Box |
Rituxan (rituximab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Rituxan is used to treat non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
Rituxan is also used in combination with another drug called methotrexate to treat symptoms of adult rheumatoid arthritis.
Rituxan is also used in combination with steroid medicines to treat certain rare disorders that cause inflammation of blood vessels and other tissues in the body.
Product Details:
Minimum Order Quantity | 1 Unit |
Dose | 300 mg |
Packaging Type | Glass Bottle |
Medicine Type | Allopathic |
Soliris (eculizumab) is a monoclonal antibody. Eculizumab binds to proteins in the blood that can destroy red blood cells in people with genetic conditions that affect the natural defenses of red blood cells.
Soliris is used to prevent the breakdown of red blood cells in people with paroxysmal nocturnal hemoglobinuria (PNH).
Soliris is also used to treat a rare chronic blood disease called atypical hemolytic uremic syndrome (aHUS).
Eculizumab is available only under a special program called Soliris REMS. You must be registered in the program and sign documents stating that you understand the risks and benefits of taking this medication.
Product Details:
Minimum Order Quantity | 1 Unit |
Dose | 250mg |
Usage | Personal, Hospital, Commercial |
Tykerb (lapatinib) is a cancer medication.
Tykerb is used together with another medicine called capecitabine or letrozole (Femara) to treat a certain type of advanced breast cancer that has spread to other parts of the body. It is often given after other cancer medications have been tried without successful treatment of symptoms.
Product Details:
Minimum Order Quantity | 10 Unit |
Packaging Type | Vial |
Packaging Size | Single Vial |
Dose/Strength | 250 mcg |
Product Details:
Packaging Size | 28 tablets |
Packaging Type | Tablets |
Dose/Strength (ex. 1 mg or 1 ml) | 40mg |
Stivarga (regorafenib) is a cancer medication that interferes with the growth and spread of cancer cells in the body.
Stivarga is used to treat colorectal cancer. It is also used to treat a rare type of tumor that can affect the esophagus, stomach, or intestines.
Stivarga is usually given after other cancer medications have been tried without success.
Product Details:
Product Type | Finished Product |
YONDELIS® is a prescription medicine used to treat people with liposarcoma or leiomyosarcoma that:
Product Details:
Minimum Order Quantity | 1 Unit |
Form | Injection |
3.5/5
Reviewed by 75 Users
Most Relevant Reviews